Provided by Tiger Trade Technology Pte. Ltd.

TOUYUN BIOTECH

0.150
+0.01410.29%
Volume:6.28M
Turnover:921.16K
Market Cap:439.35M
PE:15.79
High:0.150
Open:0.136
Low:0.130
Close:0.136
52wk High:0.750
52wk Low:0.067
Shares:2.93B
HK Float Shares:2.93B
Volume Ratio:13.30
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.010
ROE:197.38%
ROA:-3.90%
PB:3.11
PE(LYR):15.79
PS:6.20

Loading ...

Touyun Biotech: Issues 123.00 Million New Shares in September; Share Capital Climbs to 2.93 Billion

Bulletin Express
·
Oct 02

TOUYUN BIOTECH: Ruijuan Zhou Acquires, Long Position Rising to 0.96%

HK Disclosure
·
Sep 28

TOUYUN BIOTECH Grants 74.5838 Million Share Options

Stock News
·
Sep 24

Touyun Biotech Interim 2026: Profit Jumps to HK$310.80 Million on Robust Investment Gains Despite Softer Core Revenues

Bulletin Express
·
Sep 16

Touyun Biotech Publishes 2026 Interim Report; Sets Procedures for Printed Copies and E-Communication

Bulletin Express
·
Sep 16

Touyun Biotech Releases 2026 Interim Report and Details Shareholder Communication Arrangements

Bulletin Express
·
Sep 16

Touyun Biotech Files Next-Day Disclosure Return in Hong Kong, Issues 123 Million New Shares

Reuters
·
Sep 07

Touyun Biotech Completes Hk$15.01 Million Share Placement at Hk$0.122 Per Share

Reuters
·
Sep 07

Touyun Biotech Details Allocation of HK$15.01 Million Share Subscription Proceeds

Bulletin Express
·
Aug 31

Touyun Biotech Details Use of Hk$14.99 Million Net Proceeds from Share Subscription

Reuters
·
Aug 31

Touyun Biotech Reports Interim Profit Surge of Roughly 1.66 Billion Yuan

Stock News
·
Aug 28

Touyun Biotech swings to HK$310.80 million interim profit on investment revaluation; liquidity pressure remains

Bulletin Express
·
Aug 28

Hong Kong's Touyun Biotech Profit Surges on Fair Value Gains

Reuters
·
Aug 28

Touyun Biotech Group Hy Profit Attributable from Continuing Operations Hk$197.8 Mln

THOMSON REUTERS
·
Aug 28

Touyun Biotech Group Ltd - Do not Recommend the Payment of Any Interim Dividend for the Six Months Ended 30 June 2026

THOMSON REUTERS
·
Aug 28

Touyun Biotech FY26 H1 Profit from Continuing Operations Rises to Hk$310.8 Million; Revenue Falls 3.3% to Hk$35.4 Million

Reuters
·
Aug 28

Touyun Biotech projects 1,025%–1,150% interim profit leap to HK$180–200 million on investment gains

Bulletin Express
·
Aug 26

Touyun Biotech Group Sees Hk$180 Million-Hk$200 Million Profit and Total Comprehensive Income Attributable for Hy2026

Reuters
·
Aug 26

Touyun Biotech Group - Expected Hy Profit Increase Mainly Due to Hk$340 Mln Fair Value Gain on Financial Assets

THOMSON REUTERS
·
Aug 26

Touyun Biotech Group - Sees Hk$180 Mln-Hk$200 Mln Profit and Total Comprehensive Income Attributable for Six Months Ended June 30, 2026

THOMSON REUTERS
·
Aug 26